Synthetic CBD

Botanix Announces Landmark Descheduling of Synthetic CBD by the DEA

Botanix Pharma's partner in the US, Purisys, has received confirmation from the DEA that synthetic CBD has been officially removed from Schedule 1 of the Controlled Substances Act....

Weed Science – How Biosynthesis will Upend the Cannabis Industry

The global cannabis industry is currently in the midst of a greenhouse arms race.Every cannabis cultivator is competing to see who can achieve the greatest grow capacity, as the in...

Eastern Outlook – Mark Bernberg Discusses Asian Cannabis Market on Your Money Live

The world's leading market research firm, Prohibition Partners, published a report this week—entitled The Asian Cannabis Report—predicting that the Asian cannabis market will r...